In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants
NCT01203501 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1339
Last updated 2017-09-26
Summary
This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/infant conditions and magnesium exposure (including indications, timing and duration of exposure).
Conditions
- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
- Intracranial Hemorrhages
- Leukomalacia, Periventricular
- Cerebral Palsy
Sponsors & Collaborators
-
National Center for Research Resources (NCRR)
collaborator NIH -
NICHD Neonatal Research Network
lead NETWORK
Principal Investigators
-
James A. Lemons, MD · Indiana University
-
Waldemar A. Carlo, MD · University of Alabama at Birmingham
-
William Oh, MD · Brown University, Womens and Infants Hospital
-
Avroy A. Fanaroff, MD · Case Western Reserve University, Rainbow Babies & Children's Hospital
-
Edward F. Donovan, MD · Children's Hospital Medical Center, Cincinnati
-
Barbara J. Stoll, MD · Emory University
-
Ann R. Stark, MD · Brigham and Women's Hospital
-
Charles R. Bauer, MD · University of Miami
-
Lu-Ann Papile, MD · University of New Mexico
-
David K. Stevenson, MD · Stanford University
-
Sheldon B. Korones, MD · University of Tennessee
-
Jon E. Tyson, MD MPH · University of Texas Southwestern Medical Center
-
Seetha Shankaran, MD · Wayne State University
-
Richard A. Ehrenkranz, MD · Yale University
-
Raymond Bain, PhD · George Washington University
Eligibility
- Max Age
- 14 Days
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1996-07-31
- Primary Completion
- 1998-06-30
- Completion
- 2000-06-30
Countries
- United States
Study Locations
More Related Trials
-
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
NCT00014989 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Administering Intravenous Magnesium Sulfate on Fetal Cardiotocography and Neonatal Outcome in Preeclamptic Patients
NCT03237000 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of Electrolyte Intake (Sodium, Phosphorus) on the Growth of Premature Newborns
NCT06506981 ·Status: COMPLETED
-
Discontinuation of Magnesium Sulfate After Delivery in Women With Severe Preeclampsia. A Randomized Controlled Trial
NCT03318211 ·Status: UNKNOWN ·Phase: PHASE4
-
Magnesium Sulfate (MgSO4) and Fetal Heart Rate (FHR) in Case of Prematurity
NCT03956121 ·Status: COMPLETED
-
Patient Satisfaction With Abbreviated Postpartum Magnesium Sulfate for Severe Preeclampsia
NCT05789381 ·Status: WITHDRAWN ·Phase: NA
-
Consequences of Antiangiogenic Factors Involved in Preeclampsia on Intra-uterine Growth Restricted Preterm Newborn
NCT01648855 ·Status: COMPLETED
-
Serum Magnesium Concentration in Magnesium Sulfate Therapy for Severe Preeclampsia
NCT05283473 ·Status: COMPLETED
-
Effect of Magnesium Sulphate on the Intracranial Pressure of Preeclamptic Patients
NCT03210350 ·Status: COMPLETED
-
A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy
NCT02032186 ·Status: COMPLETED ·Phase: PHASE3
-
Magnesium Sulphate for Preterm Birth (MASP Study)
NCT01492608 ·Status: COMPLETED ·Phase: PHASE3
-
Role of L-citrulline in Prevention of Pregnancy Associated Hypertension
NCT04979793 ·Status: SUSPENDED ·Phase: PHASE1
-
PK/PD Modeling of Magnesium in the Mother and Neonate
NCT01709630 ·Status: COMPLETED
-
The Treatment of Magnesium Sulfate and Nifedipine in Preterm Labor Threat
NCT05520021 ·Status: UNKNOWN ·Phase: NA
-
Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection
NCT02506894 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience
NCT02454322 ·Status: COMPLETED
-
Endothelial Progenitor Cells in Umbilical Cord Blood in Preeclampsia and IUGR
NCT00634855 ·Status: TERMINATED
-
Different Schemes of Magnesium Sulfate for Preeclampsia
NCT02396030 ·Status: TERMINATED ·Phase: PHASE4
-
Magnesium Sulfate in Pregnancy and Postpartum
NCT02317146 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Risk Analysis of Intensive Care Mangement on Maternal and Fetal Outcome of Severe Preeclampsia and Eclampsia
NCT03412552 ·Status: COMPLETED
-
Aggressive Versus Expectant Management of Severe Preeclampsia Remote From Term
NCT01164852 ·Status: COMPLETED ·Phase: NA
-
Restrictive Fluid Therapy in Severe Preeclampsia
NCT02214186 ·Status: COMPLETED ·Phase: NA
-
Maternal and Neonatal Outcome in Severe Preeclampsia
NCT04126122 ·Status: UNKNOWN
-
Neurobehavioural Outcomes in Late Preterm Neonates
NCT02443259 ·Status: COMPLETED
-
Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
NCT04983069 ·Status: UNKNOWN